
Robert A. Wax
Supervisory Patent Examiner (ID: 4181, Phone: (571)272-0623 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615, 1656, 1506, 1805, 1652, 1808, 1507, 1814, 1653, 1105, 1807 |
| Total Applications | 1622 |
| Issued Applications | 930 |
| Pending Applications | 418 |
| Abandoned Applications | 279 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6406185
[patent_doc_number] => 20020182668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Human PEG3 gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/842777
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182668.pdf
[firstpage_image] =>[orig_patent_app_number] => 09842777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/842777 | Human PEG3 gene and uses thereof | Apr 26, 2001 | Abandoned |
| 09/830244 | LYSINE-RICH STATHERIN PROTEIN | Apr 22, 2001 | Abandoned |
Array
(
[id] => 985627
[patent_doc_number] => 06924357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'Lipid binding protein 4'
[patent_app_type] => utility
[patent_app_number] => 10/257637
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9739
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924357.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257637
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257637 | Lipid binding protein 4 | Apr 10, 2001 | Issued |
Array
(
[id] => 6792713
[patent_doc_number] => 20030088057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT'
[patent_app_type] => new
[patent_app_number] => 09/827542
[patent_app_country] => US
[patent_app_date] => 2001-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8720
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20030088057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09827542
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/827542 | PEPTIDE SUBSTRATES PHOSPHORYLATED BY P21-ACTIVAGED PROTEIN KINASE STATEMENT REGARDING FEDERALLY SPONSORED REASEARCH OR DEVELOPMENT | Apr 5, 2001 | Abandoned |
Array
(
[id] => 1059745
[patent_doc_number] => 06852835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses'
[patent_app_type] => utility
[patent_app_number] => 09/825414
[patent_app_country] => US
[patent_app_date] => 2001-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 43202
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852835.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825414
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825414 | DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses | Apr 2, 2001 | Issued |
Array
(
[id] => 6683127
[patent_doc_number] => 20030118991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Ataxia-telangiectasia gene and its genomic organization'
[patent_app_type] => new
[patent_app_number] => 09/825476
[patent_app_country] => US
[patent_app_date] => 2001-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22652
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118991.pdf
[firstpage_image] =>[orig_patent_app_number] => 09825476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/825476 | Ataxia-telangiectasia gene and its genomic organization | Apr 2, 2001 | Abandoned |
Array
(
[id] => 6243088
[patent_doc_number] => 20020045589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => 'Hirulog-like peptide and gene therapy'
[patent_app_type] => new
[patent_app_number] => 09/822882
[patent_app_country] => US
[patent_app_date] => 2001-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19850
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045589.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822882
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822882 | Hirulog-like peptide and gene therapy | Mar 29, 2001 | Abandoned |
Array
(
[id] => 7394174
[patent_doc_number] => 20040038359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds'
[patent_app_type] => new
[patent_app_number] => 10/240363
[patent_app_country] => US
[patent_app_date] => 2003-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10794
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038359.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240363 | Gene 763 of phytopathogenic fungus Magnaporthe grisea and use thereof for identifying fungicidal compounds | Mar 25, 2001 | Issued |
Array
(
[id] => 6509523
[patent_doc_number] => 20020025932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Purification of fibrinogen from milk by use of cation exchange chromatography'
[patent_app_type] => new
[patent_app_number] => 09/822299
[patent_app_country] => US
[patent_app_date] => 2001-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7996
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025932.pdf
[firstpage_image] =>[orig_patent_app_number] => 09822299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/822299 | Purification of fibrinogen from milk by use of cation exchange chromatography | Mar 21, 2001 | Issued |
Array
(
[id] => 6415446
[patent_doc_number] => 20020183483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Method for purification of molecules using unbranched terminal alkyldiols'
[patent_app_type] => new
[patent_app_number] => 09/813093
[patent_app_country] => US
[patent_app_date] => 2001-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 7704
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183483.pdf
[firstpage_image] =>[orig_patent_app_number] => 09813093
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/813093 | Method of purification of molecules using unbranched terminal alkyldiols | Mar 18, 2001 | Issued |
Array
(
[id] => 6899985
[patent_doc_number] => 20010009661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-26
[patent_title] => 'Method for disinfecting body fluids'
[patent_app_type] => new
[patent_app_number] => 09/735125
[patent_app_country] => US
[patent_app_date] => 2001-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20239
[patent_no_of_claims] => 152
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20010009661.pdf
[firstpage_image] =>[orig_patent_app_number] => 09735125
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/735125 | Method for disinfecting body fluids | Feb 14, 2001 | Abandoned |
Array
(
[id] => 1164553
[patent_doc_number] => 06756206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-29
[patent_title] => 'Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides'
[patent_app_type] => B2
[patent_app_number] => 09/905691
[patent_app_country] => US
[patent_app_date] => 2001-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6058
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/756/06756206.pdf
[firstpage_image] =>[orig_patent_app_number] => 09905691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/905691 | Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides | Feb 13, 2001 | Issued |
Array
(
[id] => 1062887
[patent_doc_number] => 06849597
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-01
[patent_title] => 'Neuroprotective drug'
[patent_app_type] => utility
[patent_app_number] => 10/169423
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9485
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169423
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169423 | Neuroprotective drug | Dec 27, 2000 | Issued |
Array
(
[id] => 7397127
[patent_doc_number] => 20040038873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Polypeptide-calcitonin 11 and the polynucleotide encoding it'
[patent_app_type] => new
[patent_app_number] => 10/168626
[patent_app_country] => US
[patent_app_date] => 2002-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11368
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168626
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168626 | Polypeptide-calcitonin 11 and the polynucleotide encoding it | Dec 17, 2000 | Issued |
| 09/554862 | Troponin C-I complex | Oct 29, 2000 | Abandoned |
Array
(
[id] => 1182011
[patent_doc_number] => 06737508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides'
[patent_app_type] => B1
[patent_app_number] => 09/676519
[patent_app_country] => US
[patent_app_date] => 2000-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 48190
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737508.pdf
[firstpage_image] =>[orig_patent_app_number] => 09676519
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/676519 | DNA sequences from staphylococus aureus bacteriophages 3A, 77, and 96 that encode anti-microbial polypeptides | Sep 27, 2000 | Issued |
Array
(
[id] => 1063257
[patent_doc_number] => 06849717
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon'
[patent_app_type] => utility
[patent_app_number] => 09/655160
[patent_app_country] => US
[patent_app_date] => 2000-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 18257
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849717.pdf
[firstpage_image] =>[orig_patent_app_number] => 09655160
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/655160 | Polycystic kidney disease gene homologs required for male mating behavior in nematodes and assays based thereon | Sep 4, 2000 | Issued |
Array
(
[id] => 1144437
[patent_doc_number] => 06773723
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-10
[patent_title] => 'Collagen/polysaccharide bilayer matrix'
[patent_app_type] => B1
[patent_app_number] => 09/652604
[patent_app_country] => US
[patent_app_date] => 2000-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4550
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/773/06773723.pdf
[firstpage_image] =>[orig_patent_app_number] => 09652604
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/652604 | Collagen/polysaccharide bilayer matrix | Aug 29, 2000 | Issued |
Array
(
[id] => 1037152
[patent_doc_number] => 06872384
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Treatment of trauma'
[patent_app_type] => utility
[patent_app_number] => 09/644022
[patent_app_country] => US
[patent_app_date] => 2000-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15600
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872384.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644022 | Treatment of trauma | Aug 22, 2000 | Issued |
| 09/641034 | Integrin binding motif containing peptides and methods of treating skeletal diseases | Aug 15, 2000 | Abandoned |